Addressing the Diabetes Epidemic-Advances in Screening, Detection and Prevention
This educational activity consists of recorded presentations from the 19th Annual National Conference held in Chicago, IL on September 13–15, 2010.
The conference topics have been expanded and redesigned in order to bring valuable, cutting-edge clinical topics to our learners. Conference faculty is comprised of recognized clinical and thought leaders, and sessions will focus on innovations and trends in solid organ and blood/marrow transplantation, oncology, kidney disease, heart disease, disease management, consumerism, and health and well-being.
At the end of this educational activity, participants should be able to
- Identify innovative advances and initiatives in diabetes prevention.
- Explore the impact of intensive lifestyle intervention on improved diabetes control.
David M. Kendall, MD
Chief Scientific and Medical Officer
American Diabetes Association
Please click here to view disclosures and activity planning information.
Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Participants will receive a certificate upon successful completion of the activity, which includes the following:
- Completing the entire activity
- Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms
You must be logged into your account to participate in this activity. Begin by clicking Take Course and viewing the CE Info; then follow the prompts at the bottom of the screen. At the end of the activity you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.
This activity is sponsored by OptumHealth Education.
This activity was derived from content supported by Amgen, Boehringer Ingelheim, Eisai, Centocor/Ortho Biotech Services, Cephalon Oncology, Genzyme, Takeda/ Millennium Pharmaceuticals, Novartis Pharmaceuticals and Novartis Oncology, sanofi aventis, The Children’s Hospital of Philadelphia, National Marrow Donor Program, Allos Therapeutics, and Byram Healthcare.
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software.
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance